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Purpose: We retrospectively analyzed 28 years of experience with the Bentall pro-
cedure in patients with aortic valve, aortic root, and ascending aortic disease. Ma-
terials and Methods: Between March 1982 and December 2010, a total of 218 
patients underwent the Bentall procedure using a composite valved conduit. The 
“inclusion technique” was used in 30 patients (13.8%), the “open-button tech-
nique” in 181 patients (83.0%), and the Cabrol technique in 7 patients (3.2%). Re-
sults: The early mortality rate was 5.5% (12/218). The mean follow-up duration 
was 108.0±81.0 months (range: 1-329 months). Seven patients required re-opera-
tion, and 1 patient required stent graft insertion at the descending thoracic aorta for 
progression of aortic arch or descending thoracic aortic dissection or aneurysm af-
ter the first operation, and 5 of them had Marfan syndrome. Kaplan-Meier estimat-
ed survival rates at 1, 5, 10, 20, and 25 years were 90.4%, 82.7%, 77.6%, 65.3%, 
and 60.3%, respectively. Freedom from reoperation rates at 1, 5, 10, 20, and 25 
years were 99.0%, 98.3%, 95.5%, 90.8%, and 90.8%, respectively. Conclusion: In 
our experience, the Bentall procedure provided optimal survival with improved 
functional status. The disease of the aorta may progress, especially in patients with 
Marfan syndrome. Therefore, careful follow-up with regular computed tomogra-
phy angiograms should be performed in these patients.
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INTRODUCTION
Since Bentall and De Bono1 first described composite valve graft implantation in 
1968, this well documented technique of aortic root replacement has been used for 
a large spectrum of various pathologic conditions involving the aortic valve, aortic 
root, and ascending aorta.2-4 In this study, we retrospectively reviewed and evaluat-
ed the early and long-term results of our 28-year clinical experience with the Ben-
tall procedure for various aortic diseases in 218 patients. 
MATERIALS AND METHODS
Patients’ characteristics
From March 1982 to December 2010, a total of 218 patients underwent the Ben-
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type II: 18), and annular endocarditis (9). The causes of aor-
tic disease included Marfan syndrome in 102 patients 
(46.8%), atherosclerosis in 64 patients (29.4%), congenital 
bicuspid aortic valve in 39 patients (17.9%), bacterial endo-
carditis in 9 patients (4.1%), syphilitic aortitis in 3 patients 
(1.4%), and Takayasu arteritis in one patient (0.5%). Twenty 
patients (9.8%) had previously undergone surgical interven-
tion on the aortic valve or ascending aorta, or both. Nine pa-
tients (4.1%) were in New York Heart Association (NYHA) 
functional class I, 92 patients (42.2%) in class II, 89 pa-
tients (40.8%) in class III, and 28 patients (12.8%) in class 
IV (Table 1). 
Surgical techniques
The operation was performed through a standard median 
sternotomy, and cardiopulmonary bypass was instituted by 
cannulation of the ascending aorta, aortic arch, femoral ar-
tery, or subclavian artery, and the right atrium. Myocardial 
protection was achieved by antegrade, retrograde, or simul-
taneously antegrade and retrograde intermittent cold hyper-
kalemic blood cardioplegia. The “inclusion technique” was 
performed in 30 patients (13.8%), the “open-button tech-
nique” in 181 patients (83.0%), and the Cabrol technique in 
7 patients (3.2%). In patients treated with “open-button tech-
nique”, coronary reimplantation suture lines were reinforced 
with an autologous pericardial strip or removed aortic wall. 
The Cabrol technique was used only in cases of reoperation 
because of difficulty with mobilizing and approximating 
coronary arteries to the vascular graft. 
The concomitant procedures included graft replacement 
of the ascending aorta (9); hemi arch (11), total arch (7), or 
mitral valve replacement (4); mitral annuloplasty (14), cor-
onary artery bypass grafting (21); repair of a ventricular 
septal defect (4); tricuspid valve repair (10); myectomy (2); 
and the Dor procedure (1). In cases of arch or hemi arch re-
placement, cerebral protection was obtained with deep hy-
pothermic circulatory arrest (DHCA) in 3 patients, DHCA 
and retrograde cerebral perfusion in 8 patients, and ante-
grade cerebral perfusion through the right subclavian artery 
with moderate systemic hypothermia in 7 patients.
A Bjork-Shiley composite graft prosthesis (Shiley, Inc., 
Irvine, CA, USA) was used in 11 patients; a St. Jude com-
posite graft (St. Jude Medical, Inc., St. Paul, MN, USA) in 
146 patients; a Carbomedics composite graft (Carbomed-
ics, Inc., Austin, TX, USA) in 52 patients; ATS (ATS Medi-
cal, Inc., Minneapolis, MN, USA) in 1 patient; freestyle 
stentless valve (Medtronic, Inc., Minneapolis, MN, USA) 
tall procedure using a composite valved conduit in Yonsei 
Cardiovascular Center, Yonsei University Health System. 
Our study was conducted with the approval of the Institu-
tional Review Board of Yonsei University College of Medi-
cine (Yonsei Institutional Review Board No. 4-2011-0062). 
Individual patient consent was waived. The mean patient 
age at the time of the operation was 44.4±13.9 years (range, 
13-76 years). Of these patients, 151 (69%) were male and 
67 were female (31%). The preoperative diagnoses included 
annuloaortic ectasia (144), acute aortic dissection (DeBakey 
type I: 29, type II: 9), chronic aortic dissection (type I: 12, 
Table 1. Baseline Patient Characteristics
Characteristics n (%)
Age (yrs)±SD 44.35±13.9
Male/Female      151/67 (69.3/30.7) 
Hypertension     64 (31.2)
Diabetes mellitus     9 (4.4)
CAOD   10 (4.9)
COPD     21 (10.2)
Old CVA   11 (5.4)
Previous cardiac operation   20 (9.8)
Chronic renal failure     5 (2.5)
NYHA class
    I     9 (4.1)
    II     92 (42.2)
    III     89 (40.8)
    IV     28 (12.8)
Aortic pathology
    Annuloaortic ectasia   144 (66.0)
    Dissection
        Acute     35 (16.3)
        Chronic     30 (13.8)
Marfan syndrome   102 (46.8)
Bicuspid aortic valve     39 (18.1)
Maximum diameter of ascending 
  aorta, mm±SD
56.68±19
Combined mitral valve disease     46 (21.1)
AR grade 
    I   11 (5.0)
    II     25 (11.5)
    III     85 (38.9)
    IV     97 (44.5)
LVEF (%)  54.3±13.1
LVESD, mm±SD  50.9±12.4
LVEDD, mm±SD  69.2±12.4
Emergency   21 (9.6) 
n, number; CAOD, coronary artery occlusive disease; COPD, chronic 
obstructive pulmonary disease; CVA, cerebrovascular accident; NYHA, 
New York Heart Association; AR, aortic regurgitation; LVEF, left ventricular 
ejection fraction; LVESD, left ventricular end systolic diameter; LVEDD, left 
ventricular end diastolic diameter; SD, standard deviation.
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RESULTS
 
Hospital mortality and morbidity 
The overall early mortality rate, defined as death within 30 
days of initial hospitalization, was 5.5% (12/218). Causes 
of death were low cardiac output syndrome in 3, ventricular 
arrhythmia in 3, pneumonia or acute respiratory distress 
syndrome in 2, sepsis in 2, cerebrovascular accident in 1, 
and bleeding in 1 patient (Table 3). Early complications in-
cluded re-exploration for bleeding in 21, acute renal failure 
in 20, low cardiac output syndrome in 12, upper gastroin-
testinal bleeding in 7, myocardial infarction in 4, prolonged 
mechanical ventilation in 10, pericardial effusion in 7, tran-
sient ischemic attack in 1, cerebral infarction in 1, and su-
perficial wound infection in 7 patients (Table 4A). 
Postoperative left ventricular end-systolic dimension signif-
icantly decreased from 50.9±12.4 to 43.1±11.4 mm (p< 
0.001), and left ventricular end-diastolic dimension signifi-
cantly decreased from 69.2±12.4 to 57.3±11.1 mm (p< 
0.001). The postoperative NYHA functional class also im-
proved significantly (2.59±0.76 to 1.14±0.39, p<0.001), 
and ascending aortic size measured with pre and postopera-
tive chest computed tomography (CT) decreased from 
70.0±19.9 to 32.4±4.4 mm (p<0.001). 
In hospital mortality was significantly affected by preop-
erative diabetes mellitus [odds ratio (OR) 16.62; 95% con-
fidence interval (CI) 2.58 to 106.91; p=0.003] and NYHA 
class of 3 or greater (OR 5.28; 95% CI, 1.06 to 26.10; 
p=0.041) (Table 5). 
in 5 patients; and aortic homograft in 3 patients (Table 2). 
Follow-up and statistical analysis
All patients were followed in the outpatient department with 
clinical examination, computed tomography scans and 
transthoracic echocardiography. When necessary, patients 
were interviewed via the telephone to obtain actualized in-
formation. Among 206 hospital survivors, 196 (95.1%) pa-
tients were available for follow-up (mean: 108 months). Sta-
tistical analysis was performed with the SPSS 11.0 statistical 
software package (SPSS, Chicago, IL, USA). Continuous 
variables were expressed as the mean±standard deviation, 
and compared with unpaired two-tailed t-test. Categorical 
variables were analyzed with the χ2 test or Fisher’s exact 
test, where appropriate. Univariate and multivariate analy-
sis of predictors for early and late mortality were performed 
using a logistic regression model. A p-value of <0.05 was 
considered statistically significant. Survival curves were 
constructed using the Kaplan-Meier method and compared 
with the log-rank test.   
Table 2. Operative Data
Variables n (%) 
Coronary transfer technique
    Inclusion technique    30 (13.8)
    Open-button technique  181 (83.0)
    Cabrol technique    7 (3.2) 
OP time (min)   412±130
CPB time (min) 210±78
ACC time (min) 146±51
Total circulatory arrest 22 (10)
Total circulatory arrest time (min) 44±36
Valve type
    Mechanical  213 (97.7)
    Tissue    5 (2.3)
Composite valve size (mm) 25.7±2.6
Concomitant procedure 
    CABG  21 (9.6) 
    Ascending aorta replacement    9 (4.1)
    Hemiarch replacement  11 (5.0)
    Total arch replacement    7 (3.2)
    Mitral valve repair  14 (6.4)
    Mitral valve replacement    4 (1.8)
    Tricuspid valve repair  10 (4.6)
    Myectomy    2 (0.9)
    VSD patch repair    4 (1.8)
    Dor procedure    1 (0.5)
n, number; OP, operation; CPB, cardiopulmonary bypass; ACC, aortic cross 
clamp; CABG, coronary artery bypass surgery; VSD, ventricular septal de-
fect.
Table 3. Cause of Early and Late Mortality 
Mortality n (%)
Early mortality 
    LCOS   3 (25)
    Arrhythmia   3 (25)
    Pulmonary   2 (17)
    Sepsis   2 (17)
    CVA    1 (8.3)
    Bleeding    1 (8.3)
Late mortality
   Cardiovascular deaths 15 (35)
        Congestive heart failure      4 (26.6)
        Type B dissection      4 (26.6)
        CVA      3 (20.0)
        MI      2 (13.3)
        Sudden      2 (13.3)
   Non-cardiovascular deaths    28 (65.0)
n, number; LCOS, low cardiac output syndrome; CVA, cerebrovascular ac-
cident; MI, myocardial infarction.
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deaths occurred. The most common causes of cardiac-relat-
ed death were congestive heart failure (n=4) and type B dis-
section progression (n=4). The causes of cardiac-related 
late death are listed in Table 3. 
Kaplan-Meier estimated overall survival rates for the 218 
patients (including hospital deaths) were 90.4±2.0%, 82.7 
±2.7%, 77.6±3.1%, 65.3±4.6%, and 60.3±6.4% at 1, 5, 10, 
20, and 25 years, respectively (Fig. 1A). Among the patients 
with Marfan syndrome, the overall survival rate tended to de-
cline compared to the group without Marfan syndrome, but 
did not reach statistical significance (log rank p=0.586) (Fig. 
1B). Among the patients with dissection, the overall surviv-
al rate was not different compared to the group without dis-
section (log rank p=0.550) (Fig. 2A). However, among pa-
tients with acute dissection, the overall survival rate was 
significantly lower than that of the group with chronic dis-
section (Fig. 2B). Overall survival rates between the non-
dissection group and the chronic dissection group were sim-
ilar. Among patients treated with the open-button technique, 
the overall survival rate was better than that for those treated 
with the inclusion technique or Cabrol technique (Fig. 3). 
Univariate analyses revealed that hypertension, chronic re-
nal failure, NYHA class of 3 or greater, and coronary trans-
fer technique were risk factors for late death. Multivariate 
logistic analysis identified hypertension as the only inde-
pendent risk factor for late death (OR 2.51, 95% CI, 1.14 to 
5.53; p=0.022) (Table 5).
Late morbidity 
Late complications included new onset aneurysm or dissec-
tion in 13, intracranial hemorrhage in 3, cerebral infarction 
Late mortality and survival 
The mean follow-up duration was 108.0±81.0 months 
(range: 1-329 months). During the follow-up period, 15 
cardiac-related (6.9%) and 28 non-cardiac-related (12.8%) 
Table 4A. Early Result 
Variables n (%) 
Hospital mortality 12 (5.5) 
ICU stay (day)   5.7±11.5
Hospital stay (day) 19.2±20.1
Low cardiac output syndrome 12 (5.5)
Re-exploration for bleeding 21 (9.6)
Renal failure 20 (9.2)
Perioperative myocardial infarction   4 (1.8)
Pulmonary complication 10 (4.6)
Postoperative arrhythmia (V-fib,V-tach, AV block) 15 (6.9)
Neurologic complication   2 (0.9)
GI complication   7 (3.2)
Pericardial effusion   7 (3.2)
Infection   7 (3.2)
n, number; ICU, intensive care unit; V-fib, ventricular fibrillation; V-tach, 
ventricular tachycardia; AV, atrioventricular; GI, gastrointestinal.
Table 4B. Late Mortality and Morbidity
Variables n (%) 
Mortality   43 (19.7)
Reoperation   7 (3.2)
New onset aneurysm or dissection 13 (6.0)
Neurologic complication   9 (4.1)
Pericardial effusion   5 (2.3)
Postop arrhythmia (V-fib,V-tach, AV block)   4 (1.8)
GI bleeding   3 (1.4)
Endocarditis   3 (1.4)
n, number; V-fib, ventricular fibrillation; V-tach, ventricular tachycardia; AV, 
atrioventricular; GI, gastrointestinal.
Fig. 1. Kaplan-Meier estimated survival curves. Actual survival of all patients, at a mean follow-up time of 108.0±81.0 months, following the Bentall procedure 
(A). Actual survival of Marfan and non-Marfan syndrome patients (B).
0 0
20 20
40 40
60 60
80 80
100 100
Ov
er
al
l s
ur
viv
al
 ra
te
 (%
)
Ov
er
al
l s
ur
viv
al
 ra
te
 (%
)
0 05 510 1015 1520 2025 2530 30
60.3±6.4
63.5±5.7
55.3±12.1
Log-rank p=0.586
218 116
102
137 76
59
90 47
42
50 31
18
12 5
5
4 2
1
Number at risk
Number at riskYears Years
Non-Marfan
Marfan
  Non-Marfan 
  Marfan
A B
Experience of the Bentall Procedure
Yonsei Med J   http://www.eymj.org   Volume 53   Number 5   September 2012 919
graft dehiscence and residual moderate aortic regurgitation. 
One patient required reoperation for development of a coro-
nary pseudoaneurysm 20 years after a Bentall procedure 
had been performed using the inclusion technique. Seven 
patients required re-operation for progression of aortic arch, 
descending thoracic aortic dissection or aneurysm within a 
mean of 100 months (range: 1-204 months) after the first 
in 6, gastrointestinal bleeding in 3, pericardial effusion re-
quiring pericardiocentesis in 5, arrhythmia in 4, and bacteri-
al endocarditis in 3 patients (Table 4B).
Reoperation
One patient who underwent the Bentall operation with a 
homograft required a redo Bentall operation due to homo-
Fig. 2. Kaplan-Meier estimated survival curves. Actual survival rate for non-dissection and dissection patients (A). Actual survival of non-dissection (group 
1), acute dissection (group 2) and chronic dissection (group 3) patients (B).
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Table 5. Risk Factor Analysis for Operative Death and Late Death
Variables
Operative death Late death
Univariate Multivariate Univariate Multivariate
Age 0.202 0.219
Sex (male) 0.352 0.821
Hypertension 0.346   0.010*   0.020*
Diabetes mellitus   0.019* 0.003* 0.697
CAOD 0.463 0.422
COPD 0.979 0.145
Old CVA 0.440 0.463
Previous cardiac operation 0.253 1.000
Chronic renal failure 0.223   0.024* 0.162
NYHA class ≥3   0.019* 0.041*   0.036* 0.052
Emergency 0.180 0.334
Dissection 0.348 0.550
Marfan syndrome 0.703 0.107
Bicuspid aortic valve 0.558 0.295
Combined mitral valve disease 0.755 0.140
Maximum diameter of ascending aorta 0.895 0.467
LVEF (%) 0.362 0.472
LVESD 0.372 0.719
LVEDD 0.106 0.739
Coronary transfer method 0.433 0.033 0.116
CAOD, coronary artery occlusive disease; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; NYHA, New York Heart Associa-
tion; LVEF, left ventricular ejection fraction; LVESD, left ventricular end systolic diameter; LVEDD, left ventricular end diastolic diameter.
*Statistically significant.
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complications occurred. Cerebral hemorrhage occurred in 4 
patients, two of which died from cerebral hemorrhage. Gas-
trointestinal bleeding occurred in 4 patients and coumadin 
toxicity occurred in 1 patient. All of these patients were 
treated with medical therapy and recovered. Freedom from 
anticoagulant-related complications was 95.9±1.1%, 94.2± 
1.7% and 92.9±0.2% at 5, 10 and 25 years, respectively 
(Fig. 5A). After discharge, 3 patients experienced prosthetic 
valve endocarditis. Two of these patients healed after medi-
cal therapy, while the other patient died from rupture of an 
intracranial mycotic aneurysm. Freedom from prosthetic 
valve endocarditis rate was 99.0±0.7%, 97.1±2.0% and 
97.1±2.0% at 5, 10, and 25 years, respectively (Fig. 5B). 
Freedom from prosthetic valve related complications was 
98.1±1.0%, 93.3±1.9%, 92.4±2.1% and 89.3±3.0% at 1, 5, 
10, and 25 years, respectively (Fig. 5C).
DISCUSSION
The original Bentall procedure has been widely used since 
1968 when Bentall and De Bono1 first described the tech-
nique. Over the past decades, several modifications of the 
originally described technique have been introduced, and 
have helped to improve clinical outcomes.2-5 
Although results, following introduction of the Bentall 
procedure, have steadily improved, over the last decade, vari-
ous kinds of valve-sparing operations have become an attrac-
tive alternative to replacement of the aortic root, improving 
survival with fewer complications and better quality of life, 
even in patients with Marfan syndrome.6-9 However, due to 
operation. Four of these patients had Marfan syndrome. One 
patient required stent graft insertion for descending thoracic 
aortic dissection, and he also had Marfan syndrome. The 
Kaplan-Meier analysis for freedom from reoperation is 
shown in Fig. 2. Freedom from re-operation rates for all pa-
tients at 1, 5, 10, 20, and 25 years were 99.0±0.7%, 98.3± 
1.0%, 95.5±1.7%, 90.8±3.9%, and 90.8±3.9%, respectively 
(Fig. 4A). In patients with Marfan syndrome, survival with-
out reoperation tended to decline compared to the group 
without Marfan syndrome, but this observation did not reach 
statistical significance (log rank p=0.089) (Fig. 4B).  
Freedom from prosthetic valve-related complications 
During the follow-up period, nine anticoagulant-related 
Fig. 4. Kaplan-Meier estimated freedom from reoperation. Freedom from reoperation for all patients, at a mean follow-up time of 100 months, following the 
Bentall procedure (A). Freedom from reoperation for Marfan versus non-Marfan syndrome patients (B).
Fig. 3. Kaplan-Meier estimated survival curves. Actual survival rate ac-
cording to coronary transfer technique. Inclusion (group 1), open-button 
(group 2), Cabrol (group 3).
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aneurysm, especially in patients with Marfan syndrome.11-14 
The incidence of pseudoaneurysms with this technique 
ranged from 7% to 25%.15-17 However, since aortography or 
aorta CT is not performed on all patients after the Bentall 
procedure, the true frequency may have been higher. Our 
experience also showed that the open-button technique was 
better than the inclusion technique in regards to long-term 
survival (Fig. 3). Although we have not experienced pseudo-
aneurysm during the earlier period, we had one patient who 
was re-operated for coronary pseudoaneurysm 20 years af-
ter undergoing the Bentall procedure using the inclusion 
technique. Since a long interval between the operation and 
the development of pseudoaneurysm is not unusual, contin-
uous careful follow-up of patients with imaging studies is 
suggested. We abandoned performing the inclusion tech-
nique in 1994, and the open button technique in its stead, 
which includes direct implantation of coronary buttons and 
a distal anastomosis to the completely divided ascending 
aorta, has remained the current policy for aortic root replace-
ment at our institute. We also adopted a technique of pre-
clotting the prosthesis with albumin plus autoclaving in 
1994, which further contributed to reoperation rate decline. 
The Cabrol technique was used only in cases of re-opera-
tion because of difficulties with mobilization and approxi-
mation of coronary arteries to the vascular graft or upon ex-
tensive calcification of the aneurismal aorta. 
 Numerous studies have shown different independent risk 
factors for death after the Bentall procedure.18,19 Advanced 
age, dissection, Marfan syndrome, severe ventricular dys-
function, endocarditis, previous cardiac surgery, emergency 
status, coronary artery disease, poor preoperative New York 
Heart Association functional class and left ventricle ejec-
tion fraction <35% were known as predictors of early and 
the complexity of the procedure it is still regarded as a chal-
lenging procedure, especially in emergency settings, e.g. 
cases of acute aortic dissection, and if the damaged aortic 
valve is combined with dilatation of the aortic root or a dis-
section, the Bentall procedure is required. It is also remains 
questionable as to whether a valve-sparing procedure is 
suitable only for specific patients or is more widely applica-
ble, and whether the long-term durability is better than that 
of replacement. Therefore, the modified Bentall procedure 
is likely to remain the standard approach for various aortic 
root diseases.
When Bentall and De Bono1 first performed this proce-
dure, a star valve was sutured into a tube graft to form a com-
posite graft. Since then, mechanical vales have been generally 
used. The grafts often used for the Bentall procedure are com-
posite grafts, cryo-preserved homografts, autologous pulmo-
nary valves, and stentless valves. Since the availability of 
cryo-preserved homografts is limited, we use homografts only 
in patients with active infective endocarditis. The decision 
whether to use a mechanical or biologic valve was made on 
an individual basis by the surgeon and the patient. Even 
though mechanical valves were used in most patients, the 
rates of valve-related complications seemed to be similar to 
that of sole aortic valve replacement, as previously de-
scribed by other authors.10
One of the most important portions of the Bentall proce-
dure is the coronary anastomosis technique. Three different 
anastomotic techniques have been developed over the past 
few decades: the inclusion, button, and Cabrol techniques. 
The inclusion technique, as originally described by Bentall 
and De Bono1 was until 1993 our preferred method. Many 
authors had reported a relationship between the inclusion/
wrapping technique, and the formation of coronary pseudo-
Fig. 5. Kaplan-Meier estimated freedom from prosthetic valve related complications. Kaplan-Meier estimated freedom from anti-coagulation-related compli-
cations (A), endocarditis-related complications (B), and valve-related complications (C).
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going the operation (percentage of acute aortic dissection, or 
Marfan patients, for instance), most authors report low hospi-
tal mortality, as well as a significant difference between pa-
tients receiving emergency surgery versus receiving elective 
surgery.23 In our study, the operative mortality rate was 5.5% 
which was comparable to other studies. Functional status im-
proved in most patients with good long-term outcomes.
Prosthetic valve-related complications in our study were 
also comparable to other reports. Freedom from anticoagula-
tion-related complications at 25 years was 93%. Prosthetic 
endocarditis occurred only in 3 (1.3%) of the followed pa-
tients, which was significantly lower than previously report-
ed incidences.  
In summary, we have found that, in our experience, oper-
ative mortality and long-term survival after the Bentall pro-
cedure were comparable to that in other studies, and open-
button Bentall operation can be performed with excellent 
short-term and long-term results. However, re-operation of 
the remaining aorta is not rare especially in the Marfan pop-
ulation; therefore, continuous follow-up and proper medical 
management is recommended. 
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